Drug profile · INN
prazosin hydrochloride
PRAZOSIN HYDROCHLORIDE
prazosin hydrochloride (PRAZOSIN HYDROCHLORIDE) is a adrenergic receptor alpha-1 antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — prazosin hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
prazosin hydrochloride (PRAZOSIN HYDROCHLORIDE) is a adrenergic receptor alpha-1 antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Adrenergic receptor alpha-1 antagonist
Primary target: Adrenergic receptor alpha-1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is prazosin hydrochloride?
prazosin hydrochloride (PRAZOSIN HYDROCHLORIDE) is a adrenergic receptor alpha-1 antagonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for prazosin hydrochloride?
PRAZOSIN HYDROCHLORIDE is a marketed brand name for prazosin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of prazosin hydrochloride?
prazosin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.